The consequences of suppression of anaerobic bacteria.

D. E. Fry, C. R. Schermer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Anaerobic bacteria such as Bacteroides fragilis, Peptostreptococcus species, and Fusobacterium species, when accompanied by aerobic bacteria or in the presence of dead tissue, can cause severe infections. This article discusses the most common type of anaerobic infection, i.e., infection after colonic contamination of the abdominal cavity and soft tissues. Colonic anaerobes rarely cause infections as solitary pathogens. Mixed infections of aerobes and anaerobes are treated by source control, surgical drainage and debridement, and combination antibiotic therapy. Antimicrobial treatment should cover both anaerobes and aerobes; treatment of mixed infections with anti-anaerobic agents alone is likely to result in abscess formation. Recent trends toward cost cutting and the advent of antibiotics with good coverage of both aerobes and relevant pathogenic anaerobes have led to increased single-agent therapy with cefoxitin, cefotetan, ampicillin/sulbactam, imipenem/cilastatin, ticarcillin/clavulanate, trovafloxacin/alatrofloxacin, and piperacillin/tazobactam. In the past 15 years, research has begun to focus on the gut barrier, particularly on the beneficial effects of anaerobic microflora. Directing antibiotic therapy against the anaerobe when it is involved in clinical infection is important; however, the negative consequences of anti-anaerobic antibiotic therapy on the beneficial effects of normal distal gut colonization must also be considered.

Original languageEnglish (US)
Pages (from-to)49-56
Number of pages8
JournalSurgical Infections
Volume1
Issue number1
StatePublished - 2000
Externally publishedYes

Fingerprint

Anaerobic Bacteria
Anti-Bacterial Agents
Infection
Coinfection
Therapeutics
Cefotetan
Fusobacterium
Peptostreptococcus
Ticarcillin
Cefoxitin
Bacteroides fragilis
Clavulanic Acid
Aerobic Bacteria
Abdominal Cavity
Debridement
Abscess
Drainage
Costs and Cost Analysis
Research

ASJC Scopus subject areas

  • Surgery
  • Microbiology (medical)

Cite this

Fry, D. E., & Schermer, C. R. (2000). The consequences of suppression of anaerobic bacteria. Surgical Infections, 1(1), 49-56.

The consequences of suppression of anaerobic bacteria. / Fry, D. E.; Schermer, C. R.

In: Surgical Infections, Vol. 1, No. 1, 2000, p. 49-56.

Research output: Contribution to journalArticle

Fry, DE & Schermer, CR 2000, 'The consequences of suppression of anaerobic bacteria.', Surgical Infections, vol. 1, no. 1, pp. 49-56.
Fry, D. E. ; Schermer, C. R. / The consequences of suppression of anaerobic bacteria. In: Surgical Infections. 2000 ; Vol. 1, No. 1. pp. 49-56.
@article{3e6368a9135c409c996eac65ec25e623,
title = "The consequences of suppression of anaerobic bacteria.",
abstract = "Anaerobic bacteria such as Bacteroides fragilis, Peptostreptococcus species, and Fusobacterium species, when accompanied by aerobic bacteria or in the presence of dead tissue, can cause severe infections. This article discusses the most common type of anaerobic infection, i.e., infection after colonic contamination of the abdominal cavity and soft tissues. Colonic anaerobes rarely cause infections as solitary pathogens. Mixed infections of aerobes and anaerobes are treated by source control, surgical drainage and debridement, and combination antibiotic therapy. Antimicrobial treatment should cover both anaerobes and aerobes; treatment of mixed infections with anti-anaerobic agents alone is likely to result in abscess formation. Recent trends toward cost cutting and the advent of antibiotics with good coverage of both aerobes and relevant pathogenic anaerobes have led to increased single-agent therapy with cefoxitin, cefotetan, ampicillin/sulbactam, imipenem/cilastatin, ticarcillin/clavulanate, trovafloxacin/alatrofloxacin, and piperacillin/tazobactam. In the past 15 years, research has begun to focus on the gut barrier, particularly on the beneficial effects of anaerobic microflora. Directing antibiotic therapy against the anaerobe when it is involved in clinical infection is important; however, the negative consequences of anti-anaerobic antibiotic therapy on the beneficial effects of normal distal gut colonization must also be considered.",
author = "Fry, {D. E.} and Schermer, {C. R.}",
year = "2000",
language = "English (US)",
volume = "1",
pages = "49--56",
journal = "Surgical Infections",
issn = "1096-2964",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - The consequences of suppression of anaerobic bacteria.

AU - Fry, D. E.

AU - Schermer, C. R.

PY - 2000

Y1 - 2000

N2 - Anaerobic bacteria such as Bacteroides fragilis, Peptostreptococcus species, and Fusobacterium species, when accompanied by aerobic bacteria or in the presence of dead tissue, can cause severe infections. This article discusses the most common type of anaerobic infection, i.e., infection after colonic contamination of the abdominal cavity and soft tissues. Colonic anaerobes rarely cause infections as solitary pathogens. Mixed infections of aerobes and anaerobes are treated by source control, surgical drainage and debridement, and combination antibiotic therapy. Antimicrobial treatment should cover both anaerobes and aerobes; treatment of mixed infections with anti-anaerobic agents alone is likely to result in abscess formation. Recent trends toward cost cutting and the advent of antibiotics with good coverage of both aerobes and relevant pathogenic anaerobes have led to increased single-agent therapy with cefoxitin, cefotetan, ampicillin/sulbactam, imipenem/cilastatin, ticarcillin/clavulanate, trovafloxacin/alatrofloxacin, and piperacillin/tazobactam. In the past 15 years, research has begun to focus on the gut barrier, particularly on the beneficial effects of anaerobic microflora. Directing antibiotic therapy against the anaerobe when it is involved in clinical infection is important; however, the negative consequences of anti-anaerobic antibiotic therapy on the beneficial effects of normal distal gut colonization must also be considered.

AB - Anaerobic bacteria such as Bacteroides fragilis, Peptostreptococcus species, and Fusobacterium species, when accompanied by aerobic bacteria or in the presence of dead tissue, can cause severe infections. This article discusses the most common type of anaerobic infection, i.e., infection after colonic contamination of the abdominal cavity and soft tissues. Colonic anaerobes rarely cause infections as solitary pathogens. Mixed infections of aerobes and anaerobes are treated by source control, surgical drainage and debridement, and combination antibiotic therapy. Antimicrobial treatment should cover both anaerobes and aerobes; treatment of mixed infections with anti-anaerobic agents alone is likely to result in abscess formation. Recent trends toward cost cutting and the advent of antibiotics with good coverage of both aerobes and relevant pathogenic anaerobes have led to increased single-agent therapy with cefoxitin, cefotetan, ampicillin/sulbactam, imipenem/cilastatin, ticarcillin/clavulanate, trovafloxacin/alatrofloxacin, and piperacillin/tazobactam. In the past 15 years, research has begun to focus on the gut barrier, particularly on the beneficial effects of anaerobic microflora. Directing antibiotic therapy against the anaerobe when it is involved in clinical infection is important; however, the negative consequences of anti-anaerobic antibiotic therapy on the beneficial effects of normal distal gut colonization must also be considered.

UR - http://www.scopus.com/inward/record.url?scp=0034592973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034592973&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 49

EP - 56

JO - Surgical Infections

JF - Surgical Infections

SN - 1096-2964

IS - 1

ER -